A transformer and 3D CNN-based feature fusion network with interpretable ability for Raman spectra analysis: improving the diagnosis of thyroid cancer.
2/5 보강
TL;DR
A novel multimodal deep learning framework that synergistically integrates 1D spectral and 2D spatiotemporal features that establishes a novel method for thyroid cancer diagnosis, achieving both exceptional diagnostic performance and significantly enhanced model interpretability.
OpenAlex 토픽 ·
Spectroscopy Techniques in Biomedical and Chemical Research
AI in cancer detection
Gold and Silver Nanoparticles Synthesis and Applications
A novel multimodal deep learning framework that synergistically integrates 1D spectral and 2D spatiotemporal features that establishes a novel method for thyroid cancer diagnosis, achieving both excep
APA
Yu Sun, Dandan Fan, et al. (2026). A transformer and 3D CNN-based feature fusion network with interpretable ability for Raman spectra analysis: improving the diagnosis of thyroid cancer.. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 354, 127623. https://doi.org/10.1016/j.saa.2026.127623
MLA
Yu Sun, et al.. "A transformer and 3D CNN-based feature fusion network with interpretable ability for Raman spectra analysis: improving the diagnosis of thyroid cancer.." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, vol. 354, 2026, pp. 127623.
PMID
41762798 ↗
Abstract 한글 요약
Accurate differentiation of benign and malignant thyroid lesions continues to pose a significant clinical challenge. Raman spectroscopy offers label-free molecular fingerprints of cells, yet the identification of diagnostic spectral patterns remains challenging. While artificial intelligence has been applied to analyze Raman data as one-dimensional (1D) signals, such approaches may overlook subtle nonlinear relationships across wavenumbers, particularly in cases involving spectrally similar constituents. Converting 1D spectral data into two-dimensional (2D) representations can preserve both amplitude and positional correlations, thereby uncovering latent temporal and structural features. However, such transformations risk incurring information loss, the extent of which is contingent upon the encoding strategy employed. To address this, we propose a novel multimodal deep learning framework that synergistically integrates 1D spectral and 2D spatiotemporal features, representing the first application in Raman-based thyroid cancer detection. Our model uniquely combines a Transformer to capture global dependencies in 1D spectra and a 3D-CNN to extract local spatial patterns from multiple 2D spectral transformations. These dual-modality features are adaptively fused through a multi-head cross-attention mechanism, enabling dynamic feature integration. The multimodal model ultimately achieves an accuracy of 94.7% in the identification of thyroid lesions, outperforming the unimodal Transformer and 3D-CNN models, which achieve accuracies of 91.0% and 89.4%, respectively. Notably, the multimodal model enhances interpretability by identifying contributions of key Raman peaks to the classification decision. Thus, the integration of SERS with explainable deep learning establishes a novel method for thyroid cancer diagnosis, achieving both exceptional diagnostic performance and significantly enhanced model interpretability.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Construction of hollow double shell NiMn PBA nanozymes for sensitive sarcosine detection a cascade strategy.
- Polydopamine-modified cyclodextrin metal-organic framework for efficient BCL-2 siRNA delivery in lung cancer therapy.
- Nuclear phosphoinositide signaling in cell biology and disease.
- CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction.
- Shaping a pro-carcinogenic hepatic microenvironment by TCDD: An integrated approach combining network toxicology, machine learning, molecular docking, molecular dynamics and experimental validation.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.